Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

2,490.00p
   
  • Change Today:
    -5.00p
  • 52 Week High: 2,510.00
  • 52 Week Low: 1,424.00
  • Currency: UK Pounds
  • Shares Issued: 66.04m
  • Volume: 49,929
  • Market Cap: £1,644.33m
  • RiskGrade: 128

Latest ShareCast News

Genus delivers 'strong' underlying group trading performance in FY25

By Iain Gilbert

Date: Tuesday 15 Jul 2025

(Sharecast News) - Animal genetics firm Genus said on Tuesday that it had delivered a "strong" underlying group trading performance in the year ended 30 June, in line with expectations.

Genus ShareCast News

London close: Stocks finish higher as US economy... 30-Apr-2025 ShareCast
Genus taps Andy Russell for CFO 13-Mar-2025 ShareCast
Genus's bottom line hit by write-downs 27-Feb-2025 ShareCast
London close: Stocks firmer after UK, US inflati... 15-Jan-2025 ShareCast
Genus sees FY profit at top end of expectations ... 15-Jan-2025 ShareCast

Genus Regulatory News

Block Listing Six Monthly Return 01-Aug-2025 10:10 RNS
Total Voting Rights 01-Aug-2025 10:05 RNS
FY25 Trading Update 15-Jul-2025 07:00 RNS
Appointment of Financial Adviser & joint Broker 09-May-2025 09:25 RNS
Total Voting Rights 01-May-2025 14:28 RNS

Genus Newspaper Links

GENUS PROFIT BOOSTED 07-Sep-2011 Express & Star
Genus shares jump on bid talk 20-May-2008 The Scotsman
SLI’s high flyer pushes toward UK’s top slot 24-Dec-2007 The Herald
Extra security 07-Aug-2007 The Scotsman
Look ahead 16-Sep-2006 Times

Genus Tips & Analysis

Investment Column:Genus 09-Sep-2011 The Independent
Investment Column:Genus 05-Jul-2011 The Independent
Questor : Genus 02-Jun-2011 Telegraph
Questor:Genus 24-Feb-2011 Telegraph
FTSE close: Barclays down; Invensys, Tullow Oil up 08-Sep-2010 Daily Mail

Genus News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 2,490.00p
Change Today -5.00p
% Change -0.20 %
52 Week High 2,510.00
52 Week Low 1,424.00
Volume 49,929
Shares Issued 66.04m
Market Cap £1,644.33m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.53% below the market average92.53% below the market average92.53% below the market average92.53% below the market average92.53% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
70.48% above the market average70.48% above the market average70.48% above the market average70.48% above the market average70.48% above the market average
77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average
Income
98.33% below the market average98.33% below the market average98.33% below the market average98.33% below the market average98.33% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
91.97% below the market average91.97% below the market average91.97% below the market average91.97% below the market average91.97% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 6
Buy 2
Neutral 0
Sell 1
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 06-Mar-25 07-Nov-24
Paid 04-Apr-25 06-Dec-24
Amount 10.30p 21.70p

Trades for 01-Aug-2025

Time Volume / Share Price
16:36 1 @ 2,490.00p
16:36 1,063 @ 2,490.00p
16:35 28,985 @ 2,490.00p
16:35 74 @ 2,490.00p
16:35 58 @ 2,490.00p

Genus Key Personnel

CEO Jorgen Kokke
CFO Andy Russell

Top of Page